¡Sorpréndeme!
Biocon Plays The Biosimilars Card
2022-02-25
3
Dailymotion
Videos relacionados
Biocon Says New Biosimilars To Drive Growth For Next 5 Years
Kiran Mazumdar Shaw of Biocon on biosimilar & business outlook
Biocon Jumps On FDA's Letter On Mylan's Biosimilar
Biocon Eyes First Mover Advantage With Launch Of Neulasta Biosimilar
What is medical interchangeability and how does it apply to Biosimilars?
EU will den Zugang zu Biosimilars für Patienten fördern
Biocon Rallies On FDA's Letter On Mylan's Biosimilar
Biocon Outlook On The Biosimilar Sales | NDTV Profit
Biosimilars: a cheaper yet equally efficient alternative to name-brand medications
주간아이돌 - (Weeklyidol EP.16) Kim Hyun-jung Keywords Part1
